Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T21:02:55.198Z.
Calculation as of: 2026-10-06T21:02:55.198Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2828d634106ca83d862f06563bd3207250bf68b7c28fdcde625e8fc73480fe95
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Ocular Therapeutix, Inc.
Market Cap
$1.61B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.61B
Operating Cash Flow Yield
6.59%
TTM Avg
8.13%
3Y Avg
8.13%
5Y Avg
8.13%
Market Cap
$1.61B
Operating Cash Flow Yield
11.33%
TTM Avg
8.73%
3Y Avg
11.09%
5Y Avg
7.96%
Market Cap
$1.60B
Operating Cash Flow Yield
N/A
TTM Avg
30.89%
3Y Avg
30.58%
5Y Avg
30.58%
Market Cap
$1.62B
Operating Cash Flow Yield
3.49%
TTM Avg
2.59%
3Y Avg
2.30%
5Y Avg
2.30%
Market Cap
$1.63B
Operating Cash Flow Yield
11.65%
TTM Avg
10.76%
3Y Avg
8.69%
5Y Avg
6.98%
Market Cap
$1.59B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.57B
Operating Cash Flow Yield
N/A
TTM Avg
5.00%
3Y Avg
5.00%
5Y Avg
5.00%
Market Cap
$1.54B
Operating Cash Flow Yield
N/A
TTM Avg
1.93%
3Y Avg
1.93%
5Y Avg
1.93%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ocular Therapeutix, Inc. (OCUL) | $1.61B | N/A | N/A | N/A | N/A |
| Septerna Inc (SEPN)vs › | $1.61B | 6.59% | 8.13% | 8.13% | 8.13% |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 11.33% | 8.73% | 11.09% | 7.96% |
| uniQure N.V. (QURE)vs › | $1.60B | N/A | 30.89% | 30.58% | 30.58% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.62B | 3.49% | 2.59% | 2.30% | 2.30% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 11.65% | 10.76% | 8.69% | 6.98% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | N/A | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | N/A | 5.00% | 5.00% | 5.00% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | N/A | 1.93% | 1.93% | 1.93% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 12.46% | 11.11% | 11.89% | 16.15% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
